EP2101736A4 - Homogeneous paste and gel formulations - Google Patents

Homogeneous paste and gel formulations

Info

Publication number
EP2101736A4
EP2101736A4 EP07869573A EP07869573A EP2101736A4 EP 2101736 A4 EP2101736 A4 EP 2101736A4 EP 07869573 A EP07869573 A EP 07869573A EP 07869573 A EP07869573 A EP 07869573A EP 2101736 A4 EP2101736 A4 EP 2101736A4
Authority
EP
European Patent Office
Prior art keywords
gel formulations
homogeneous paste
homogeneous
paste
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07869573A
Other languages
German (de)
French (fr)
Other versions
EP2101736A2 (en
Inventor
Hassan Nached
Keith Freehauf
Peter Hanson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merial Ltd
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2006/048672 external-priority patent/WO2007075827A2/en
Priority claimed from US11/713,881 external-priority patent/US20080027011A1/en
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of EP2101736A2 publication Critical patent/EP2101736A2/en
Publication of EP2101736A4 publication Critical patent/EP2101736A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP07869573A 2006-12-19 2007-12-19 Homogeneous paste and gel formulations Withdrawn EP2101736A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US2006/048672 WO2007075827A2 (en) 2005-12-20 2006-12-19 Homogeneous paste formulations
US11/713,881 US20080027011A1 (en) 2005-12-20 2007-03-05 Homogeneous paste and gel formulations
PCT/US2007/088225 WO2008077130A2 (en) 2006-12-19 2007-12-19 Homogeneous paste and gel formulations

Publications (2)

Publication Number Publication Date
EP2101736A2 EP2101736A2 (en) 2009-09-23
EP2101736A4 true EP2101736A4 (en) 2012-09-19

Family

ID=40984939

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07869573A Withdrawn EP2101736A4 (en) 2006-12-19 2007-12-19 Homogeneous paste and gel formulations

Country Status (4)

Country Link
EP (1) EP2101736A4 (en)
CA (1) CA2673193C (en)
MX (1) MX2009006656A (en)
WO (1) WO2008077130A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102419769B1 (en) 2016-08-11 2022-07-13 아다미스 파마슈티칼스 코포레이션 drug composition
WO2019113493A1 (en) 2017-12-08 2019-06-13 Adamis Pharmaceuticals Corporation Drug compositions
CA3087822C (en) * 2018-01-18 2022-08-02 Zoetis Broomhill Ip Limited Internal teat sealants and their use in the prevention of bovine mastitis in the dry cow
US10857151B1 (en) * 2020-02-21 2020-12-08 Villya LLC Treatment of female genital schistosomiasis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
EP1701691A4 (en) * 2003-12-22 2009-11-04 Imrex Inc Methods and compositions for oral hygiene
WO2006089082A2 (en) * 2005-02-17 2006-08-24 Velcera Pharmaceuticals Transmucosal administration of drug compositions for treating and preventing disorders in animals

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
WO2008077130A2 (en) 2008-06-26
CA2673193C (en) 2014-08-05
WO2008077130A3 (en) 2008-08-21
MX2009006656A (en) 2009-08-07
CA2673193A1 (en) 2008-06-26
EP2101736A2 (en) 2009-09-23

Similar Documents

Publication Publication Date Title
IL183332A0 (en) Capsaicinoid gel formulation and uses thereof
HK1147278A1 (en) Gel composition and cosmetic preparation
IL242883B (en) Arylamino- and heteroarylamino-substituted dioxoazolines and pharmaceutical compositions comprising them
GB0414825D0 (en) Gel formulations and uses thereof
ZA201003761B (en) Polysaccharide gel formulation
IL194688A0 (en) Rapid acting and long acting insulin combination formulations
GB0422525D0 (en) Dermatological compositions and methods
IL180762A (en) Insulin-oligomer conjugates and formulations and uses thereof
EP1941901A4 (en) An exterior-applied formulation and its preparation methods and uses
IL213365A (en) Imidazopyrazine and pharmaceutical compositions comprising the same
EP1988922A4 (en) Protein formulations
HK1146220A1 (en) Gel technology suitable for use in cosmetic compositions
IL191072A0 (en) Therapeutic compositions and methods
EP2008643A4 (en) Gel composition and pack cosmetic using the same
HK1121343A1 (en) Homogeneous paste formulations
ZA201104263B (en) Perfluorocarbon gel formulations
EP2042152A4 (en) Gel composition
PL2066408T3 (en) Xanthoxyline-based composition and cosmetic use thereof
EP2124897A4 (en) Stable anti-nausea oral spray formulations and methods
PL2012805T3 (en) Therapeutic composition and use
EP2057980A4 (en) Gel cosmetic composition
GB0614365D0 (en) Pharmaceutical compositions and their use
GB0517627D0 (en) Bus-bar and connector
EP2101736A4 (en) Homogeneous paste and gel formulations
ZA201101988B (en) Antimicrobial sucralfate paste methods and compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090709

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20120820

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/14 20060101AFI20120813BHEP

Ipc: A61K 31/7048 20060101ALI20120813BHEP

Ipc: A61K 31/4152 20060101ALI20120813BHEP

Ipc: A61K 31/495 20060101ALI20120813BHEP

Ipc: A61K 31/365 20060101ALI20120813BHEP

Ipc: A61K 9/06 20060101ALI20120813BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130319